Atherosclerosis and Cardiovascular Diseases
Atherosclerosis and Cardiovascular Diseases is a research topic within Immunology. Science Explorer counts 29k research works in it since 1950. 16.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the immunological mechanisms involved in the development and progression of atherosclerosis. It covers topics such as the role of immune response, inflammation, oxidized LDL, regulatory T cells, cytokines, dendritic cells, adaptive immunity, and the LOX-1 receptor in atherosclerosis. The papers explore how T cell activation and B cell responses contribute to the pathogenesis of atherosclerosis.
- Atherosclerosis
- Immune Response
- Inflammation
- Oxidized LDL
- Regulatory T Cells
- Cytokines
- Dendritic Cells
- Adaptive Immunity
- LOX-1 Receptor
- T Cell Activation
- Research works
- 29k fractional, since 1950
- In the world top 10%
- 4.9k per year above
- Top-10% rate
- 16.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +8% the tick is no change
Which countries lead Atherosclerosis and Cardiovascular Diseases research?
By volume, China and the United States publish the most (1.3k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.3k works
- 2 United States 1.1k works
- 3 Germany 195 works
- 4 Russia 171 works
- 5 India 163 works
- 6 Italy 157 works
- 7 Japan 155 works
- 8 United Kingdom 154 works
- 9 Spain 128 works
- 10 France 120 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Atherosclerosis and Cardiovascular Diseases research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Atherosclerosis and Cardiovascular Diseases research, followed by Capital Medical University and Brigham and Women's Hospital.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 41 works
- 2 Capital Medical UniversityChina 23 works
- 3 Brigham and Women's HospitalUnited States 21 works
- 4 Karolinska InstitutetSweden 19 works
- 5 Harvard UniversityUnited States 18 works
- 6 University of VirginiaUnited States 17 works
- 7 Central South UniversityChina 16 works
- 8 Nanjing Medical UniversityChina 16 works
- 9 InsermFrance 16 works
- 10 Huazhong University of Science and TechnologyChina 15 works
Who are the leading researchers in Atherosclerosis and Cardiovascular Diseases?
The most-cited researchers publishing on Atherosclerosis and Cardiovascular Diseases include Alireza Esteghamati, Amirhossein Sahebkar and Valentı́n Fuster.
- 1 Alireza Esteghamati Iran 6.1k citations
- 2 Amirhossein Sahebkar Iran 5.6k citations
- 3 Valentı́n Fuster United States 5.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Atherosclerosis and Cardiovascular Diseases research done?
The largest centres of Atherosclerosis and Cardiovascular Diseases research in 2022–2025 are Beijing (China), Shanghai (China), Moscow (Russia) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nashville.
Largest cities, 2022–2025
Where it is the local speciality
- NashvilleUS · 25.8 works5.6×
Location quotient: how much more of its research is in Atherosclerosis and Cardiovascular Diseases than the world average.
Where is the best place to study Atherosclerosis and Cardiovascular Diseases?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Karolinska Institutet and Capital Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 68.0 | 28.0% | 8.7× | 41 | +11.6% |
| 2 | Karolinska InstitutetSweden | 59.8 | 14.7% | 9.1× | 19 | +45.1% |
| 3 | Capital Medical UniversityChina | 54.4 | 22.6% | 8.1× | 23 | +6.3% |
| 4 | National and Kapodistrian University of AthensGreece | 50.8 | 28.5% | 4.7× | 11 | +131.2% |
| 5 | Shanghai University of Traditional Chinese MedicineChina | 47.9 | 34.5% | 8.6× | 8 | -53.9% |
| 6 | Shanxi Medical UniversityChina | 47.6 | 17.3% | 12.4× | 13 | -1.3% |
| 7 | Medical University of ViennaAustria | 47.6 | 13.5% | 8.3× | 12 | +43.2% |
| 8 | Nanjing Medical UniversityChina | 46.1 | 23.8% | 6.5× | 16 | +5.6% |
| 9 | Harbin Medical UniversityChina | 45.9 | 16.2% | 12.0× | 12 | -1.5% |
| 10 | Ludwig-Maximilians-Universität MünchenGermany | 44.0 | 32.0% | 3.3× | 10 | +42.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Atherosclerosis and Cardiovascular Diseases research growing?
Output in 2018–2022 was 8% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Atherosclerosis and Cardiovascular Diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.